Qrono: Qrono Announces Positive Preclinical ProofOfConcept Results Of Novel Targeted LocoRegional Oncology Delivery Platform QARRUS
QARRUS targets the delivery of chemotherapy to tumors CSCs and their supporting TAMs and MDSCs.PITTSBURGH PA PRWEB July 28 2016 Qrono Inc. a specialty pharmaceutical company focused on longacting injectables LAIs today announced positive preclinical in vi...
Read full article »
CEO
Qrono's headquarters is located in Pittsburgh, Pennsylvania. Qrono generates $1M in revenue per employee Qrono has 1 followers on Owler.